BBLG
Bone Biologics
BBLG
BBLG
2 hedge funds and large institutions have $5.56K invested in Bone Biologics in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 6 closing their positions.
Holders
2
Holders Change
-6
Holders Change %
-75%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $5.54K | 1,225 | -5,462 | -82% |
|
2
Wells Fargo
San Francisco,
California
| $19 | 4 | -19 | -83% |
|
3
Walleye Capital
New York
| – | – | -270,199 | Closed |
|
4
Geode Capital Management
Boston,
Massachusetts
| – | – | -16,013 | Closed |
|
5
MML Investors Services
Springfield,
Massachusetts
| – | – | -15,000 | Closed |
|
6
Citadel Advisors
Miami,
Florida
| – | – | -11,335 | Closed |
|
|
VF
7
Virtu Financial
New York
| – | – | -11,248 | Closed |
|
8
UBS Group
Zurich,
Switzerland
| – | – | -135 | Closed |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|